Abstract
The gut–brain axis (GBA) is a complex communication network interfacing the gut and the brain of a single individual. The central (CNS) and enteric (ENS) nervous systems are, of course, communicating; however, other pathways are involved in GBA, among which are immune activation, intestinal barrier function, and enteroendocrine signaling. All these communication lines are bidirectional and involve neuro-immuno-endocrine mediators. The reason for the development of such a complex network is to maintain gastrointestinal homeostasis keeping in mind its links with cognitive and affective functions. Recently, the role of enteric flora, or microbiota, has been recognized as a part of the gut–brain axis. The gut microbiota can modulate brain function, forming a crucial link in the bidirectional interactions between the intestine and the nervous system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rhee SH, Pothoulakis C, Mayer EA (2009) Principles and clinical implications of the brain–gut–enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6(5):306–314. doi:10.1038/nrgastro.2009.35306-14
Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28:203–209
Burokas A, Moloney RD, Dinan TG, Cryan JF (2015) Microbiota regulation of the mammalian gut-brain axis. Adv Appl Microbiol 91:1–62, chapter 1, Elsevier Inc
Mayer EA, Savidge T, Shulman RJ (2014) Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146:1500–1512
Chen J, Li Y, Tian Y, Huang C, Li D, Zhong Q, Ma X (2015) Interaction between microbes and host intestinal health: modulation by dietary nutrients and gut-brain-endocrine-immune axis. Curr Protein Pept Sci 16:1–12
Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoraides TC (2015) Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37:984–995
Van De Sande MMH, Van Buul VJ, Brouns FJPH (2014) Autism and nutrition: the role of the gut-brain axis. Nutr Res Rev. doi:10.1017/S0954422414000110
Mezzelani A, Landini M, Facchiano F, Raggi ME, Villa L, Molteni M, DeSantis B, Brera C, Caroli AM, Milanesi L, Marabotti A (2015) Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis. Nutr Neurosci 18:145–161
Nemani K, Hosseini Ghomi R, McCormick B, Fan X (2015) Schizophrenia and the gut-brain axis. Prog Neuropsychopharmacol Biol Psychiatry 56:155–160
Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol 21(37):10609–10620
Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors. Nat Rev Neurol 11(11):625–636
Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL (2012) Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q 83(1):91–102
Catassi C, Elli L, Bonaz B, Bouma G, Carroccio A, Castillejo G, Cellier C, Cristofori F, de Magistris L, Dolinsek J, Dieterich W, Francavilla R, Hadjivassiliou M, Holtmeier W, Körner U, Leffler DA, Lundin KE, Mazzarella G, Mulder CJ, Pellegrini N, Rostami K, Sanders D, Skodje GI, Schuppan D, Ullrich R, Volta U, Williams M, Zevallos VF, Zopf Y, Fasano A (2015) Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): the Salerno experts’ criteria. Nutrient 7(6):4966–4977
Wakefield AJ (2002) The Gut–Brain Axis in childhood developmental disorders. J Pediatr Gastroenterol Nutr 34:S14–S17
Butterworth RF (2000) Complications of cirrhosis III hepatic encephalopathy. J Hepatol 32(suppl 1):171–180
Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, Dumitrascu DL (2014) The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry 2:4–11
Gershon MD (1988) The second brain: a groundbreaking new understanding of nervous disorders of the stomach and intestine. Harper & Collins, New York
Mayer EA (2000) The neurobiology of stress and gastrointestinal disease. Gut 47:861–869
De Magistris L, Picardi A, Sapone A, Cariello R, Siniscalco D, Bravaccio C, Pascotto A (2014) Intestinal barrier in autism. In: Patel VB (ed) Comprehensive guide to autism. Springer, New York, p 123
Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Solanas G, Cortina C, Sevillano M, Battle E (2011) Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol 13:1100–1107
Ulluwishewa D, Anderson RC, McNabb WC et al (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141:769–776
Catassi C, Fasano A (2008) Celiac disease. Curr Opin Gastroenterol 24:687–691
Vaarala O (2011) The gut as a regulator of early inflammation in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 18:241–247
Bjarnason I, MacPherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581
Fasano A (2011) Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity and cancer. Physiol Rev 91:151–175
D’Eufemia P, Celli M, Finocchiaro R et al (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr 85:1076–1079
De Magistris L, Familiari V, Pascotto A et al (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51:418–424
De Magistris L, Picardi A, Siniscalco D et al (2013) Antibodies against food antigens in patients with Autistic Spectrum Disorder. Biomed Res Int. doi:10.1155/2013/729349
Lerner A, Matthias T (2015) Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 14:479–489
Kramer P, Bressan P (2015) Human as superorganisms: how microbes, viruses, imprinted genes, and other selfish entities shape our behaviour. Perspect Psychol Sci 10:464–481
Rizzetto L, Weil T, Cavalieri D (2015) Systems level dissection of Candida recognition by Dectins: a matter of fungal morphology and site of infection. Pathogens 4:639–661
Crumeyrolle-Arias M, Jaglin M, Bruneau A, Vancassel S, Cardona A, Daugé V, Naudon L, Rabot S (2015) Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 42:207–217
Wang Y, Kasper LH (2014) The role of microbiome in central nervous system disorders. Brain Behav Immun 38:1–12
Critchfield JW, van Hemert S et al (2011) The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011:161358
Ghaisas S, Maher J, Kanthasamy A (2015) Gut microbiome in health and disease: linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 158:52–62, pii: S0163-7258(15)00225-9
Sandler RH, Finegold SM, Bolte ER et al (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15:429–435
Serda Kantarcioglu A, Kiraz N, Aydin A (2015) Microbiota-Gut-Brain axis: yeast species isolated from stool samples of children with suspected or diagnosed autism spectrum disorders and in vitro susceptibility against nystatin and fluconazole. Mycopathologia. doi:10.1007/s11046-015-9949-3
Semon BA (2014) Dietary cyclic dipeptides, apoptosis and psychiatric disorders: a hypothesis. Med Hypotheses 82:740–743
Zhou L, Foster JA (2015) Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat 11:715–723
Siniscalco D, Antonucci N (2013) Involvement of dietary bioactive proteins and peptides in autism spectrum disorders. Curr Protein Pept Sci 14(8):674–679
Reichelt KL, Knivsberg AM (2009) The possibility and probability of a gut-to-brain connection in autism. Ann Clin Psychiatry 21(4):205–211
Trivedi MS, Shah JS, Al-Mughairy S, Hodgson NW, Simms B, Trooskens GA, Van Criekinge W, Deth RC (2014) Food-derived opioid peptides inhibit cysteine uptake with redox and epigenetic consequences. J Nutr Biochem 25(10):1011–1018
Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, Bellando J, Pavliv O, Rose S, Seidel L, Gaylor DW, James SJ (2012) Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord 42(3):367–377
Lionetti E, Leonardi S, Franzonello C, Mancardi M, Ruggieri M, Catassi C (2015) Gluten psychosis: confirmation of a new clinical entity. Nutrients 7(7):5532–5539
Shattock P, Whiteley P (2002) Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 6(2):175–183
Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N (2013) Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord 43(11):2686–2695
Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N (2014) The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. J Neuroinflammation 11:78
O’Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF (2015) Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32–48
de Theije CG, Koelink PJ, Korte-Bouws GA, Lopes da Silva S, Korte SM, Olivier B, Garssen J, Kraneveld AD (2014) Intestinal inflammation in a murine model of autism spectrum disorders. Brain Behav Immun 37:240–247
Baganz NL, Blakely RD (2013) A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci 4(1):48–63
MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176(1):149–169
Van Elst K, Bruining H, Birtoli B, Terreaux C, Buitelaar JK, Kas MJ (2014) Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. Neurosci Biobehav Rev 45:369–738
Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX (2015) Autistic children exhibit decreased levels of essential fatty acids in red blood cells. Int J Mol Sci 16(5):10061–10076
Siniscalco D (2014) Adhesion G-protein coupled receptors in autism. Autism Open Access 4, e126. doi:10.4172/2165-7890.1000e126
Marí-Bauset S, Llopis-González A, Zazpe I, Marí-Sanchis A, Suárez-Varela MM (2015) Nutritional impact of a gluten-free casein-free diet in children with autism spectrum disorder. J Autism Dev Disord 46:673–684 [Epub ahead of print]
Ming X, Stein TP, Barnes V, Rhodes N, Guo L (2012) Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 11:5856–5862
Fang X (2015) Potential role of gut microbiota and tissue barriers in Parkinson’s disease and amyotrophic lateral sclerosis. Int J Neurosci Oct 16:1–6
Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1–S5
Natale G, Pasquali L, Paparelli A, Fornai F (2011) Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterol Motil 23:1056–1065
Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH (2014) Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson’s disease. Mov Disord 29(8):999–1009
Severance EG, Prandovszky E, Castiglione J, Yolken RH (2015) Gastroenterology issues in schizophrenia: why the gut matters. Curr Psychiatry Rep 17(5):27
Dash S, Clarke G, Berk M, Jacka FN (2015) The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry 28(1):1–6
Naseribafrouei A, Hestad K, Avershina E et al (2014) Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 26(8):1155–1162
Telesford K, Ochoa-Repáraz J, Kasper LH (2014) Gut commensalism, cytokines, and central nervous system demyelination. J Interferon Cytokine Res 34(8):605–614
Ochoa-Repáraz J, Kasper LH (2014) Gut microbiome and the risk factors in central nervous system autoimmunity. FEBS Lett 588(22):4214–4222
Mu Q, Zhang H, Luo XM (2015) SLE: another autoimmune disorder influenced by microbes and diet? Front Immunol 6:608
Sánchez B, Hevia A, González S, Margolles A (2015) Interaction of intestinal microorganisms with the human host in the framework of autoimmune diseases. Front Immunol 6:594
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
de Magistris, L., Siniscalco, D., Bravaccio, C., Loguercio, C. (2016). Gut–Brain Axis: A New Revolution to Understand the Pathogenesis of Autism and Other Severe Neurological Diseases. In: Grossi, E., Pace, F. (eds) Human Nutrition from the Gastroenterologist’s Perspective. Springer, Cham. https://doi.org/10.1007/978-3-319-30361-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-30361-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30359-8
Online ISBN: 978-3-319-30361-1
eBook Packages: MedicineMedicine (R0)